Study of feto-maternal outcomes of pregnant women with severe pre-eclampsia and eclampsia attending a tertiary care hospital of Kolhan region

Soumya R. Kar; Anjali Srivastava; Manju M. Bara; Ela Jha

doi:10.18203/2320-1770.ijrcog20243943

Authors

Soumya R. Kar Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College and Hospital, Jamshedpur, Jharkhand, India
Anjali Srivastava Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College and Hospital, Jamshedpur, Jharkhand, India
Manju M. Bara Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College and Hospital, Jamshedpur, Jharkhand, India
Ela Jha Department of Obstetrics and Gynecology, Mahatma Gandhi Memorial Medical College and Hospital, Jamshedpur, Jharkhand, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20243943

Keywords:

Severe pre-eclampsia, Eclampsia, Maternal outcomes, Fetal outcomes, Kolhan region

Abstract

Background: Hypertensive disorders in pregnancy, particularly severe pre-eclampsia and eclampsia, are significant contributors to maternal morbidity and mortality, especially in developing regions. In India, these conditions are the third leading cause of maternal mortality. This study aims to evaluate maternal and fetal outcomes in women with severe pre-eclampsia and eclampsia in a tertiary care hospital serving Jharkhand's Kolhan region, focusing on rural and tribal populations to understand demographic and clinical risk factors.

Methods: This hospital-based, prospective cohort study was conducted from September 2022 to September 2024 at Mahatma Gandhi Memorial Medical College and Hospital, Jamshedpur, India. A total of 120 pregnant women diagnosed with severe pre-eclampsia (blood pressure ≥160/110 mmHg with organ damage) or eclampsia (seizures associated with pre-eclampsia) were included. Data on sociodemographic characteristics, clinical presentations, and outcomes were collected and analysed using descriptive and inferential statistics, with a p-value <0.05 considered significant.

Results: Of the participants, 73.33% were from rural areas, 73.33% were tribal, and 40.83% were under 20 years of age. Severe pre-eclampsia was present in 61.7% of cases, while eclampsia affected the rest. High rates of maternal complications, including HELLP syndrome (20.83%), acute renal failure (15%), and postpartum hemorrhage (15%), were observed. Adverse fetal outcomes included low birth weight (43.33%), preterm births (69.17%), and NICU admissions (26.67%).

Conclusions: Severe pre-eclampsia and eclampsia in Jharkhand’s Kolhan region disproportionately affect young, rural, and tribal women. Findings underscore the need for improved antenatal care, early diagnosis, and community health interventions to reduce maternal and neonatal morbidity in high-risk populations.

Metrics

Metrics Loading ...

References

United Nations General Assembly. United Nations Millennium Declaration. A/RES/55/2. 1-9-2000. UN General Assembly, 55th session, agenda item 60(b).

Freedman LP, Waldman RJ, de Pinho H, Wirth ME, Chowdhury AMR, Rosenfield A. Transforming health systems to improve the lives of women and children. Lancet. 2005;365:997-1000.

Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Catherine YS. Williams Obstetrics. 24th Ed. New York, NY: McGraw Hill Companies; 2014.

Conde-Agudelo A, Villar J, Lindeheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol. 2004;104(6):1367-91.

Pillai SS. Fetomaternal outcome in severe preeclampsia and eclampsia: a retrospective study in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2017;6:3937-41.

Sherri AL, Chi PD, Gabisella P. Pre-eclampsia and Eclampsia Revisited. S Afr Med J. 2003;96:891-9.

Chuppana R, Atluri M, Pulidindi S, Satyala P, Syed S. A study of maternal deaths from preeclampsia and eclampsia in a tertiary care centre. IAIM. 2018;5(1):6-10.

Choudhury A, Shahsavar Y, Sarkar K, Choudhury MM, Nimbarte AD. Exploring Perceptions and Needs of Mobile Health Interventions for Nutrition, Anemia, and Preeclampsia among Pregnant Women in Underprivileged Indian Communities: A Cross-Sectional Survey. Nutrients. 2023;15(17):3699.

Douglas KA, Redman CW. Eclampsia in the United Kingdom. BMJ 1994;309:1395-400.

Farag K, Hassan I, Ledger WL. Prediction of pre-eclampsia. Obstet Gynecol Surv. 2004;59:464-82.

Pillai SS. Fetomaternal outcome in severe preeclampsia and eclampsia: a retrospective study in a tertiary care centre. Int J Reprod Contracept Obstet Gynecol. 2017;6:3937-41.

Khedagi AM, Bello NA. Hypertensive Disorders of Pregnancy. Cardiol Clin. 2021;39(1):77-90.

Jindal M, Jindal D, Naik V, Sahasrabhojanee M, Pednekar G. Epidemiology and fetomaternal outcomes in cases of imminent eclampsia and eclampsia- retrospective study. Indian J Obstet Gynecol Res. 2021;8(1):39-48.

Shivalingappa S, Shivalingappa J, Priyadarshini M, Shivalingappa B. Maternal and perinatal outcome in severe pre-eclampsia in a Tertiary Care Center. Ind J Obstet Gynecol. 2023;11(4):137-42.

Naz MK, Yousaf RT, Shaikh AG, Khattak SN, Hassan S, Sumayya. Fetal outcome in women of pre-eclampsia. J Healt Rehabilit Res. 2024;4(1):28-31.

Goyal P, Kumar Shukla P, Meena P, Saxena B, Prasad Rawat R, Meena S. Fetomaternal outcome in early onset severe pre eclampsia. Int J Adv Res (Indore). 2023;11(06):133-8.

Hassan M, Adly Elbishry GM, Sweed MS, Rasheedy Ali R. Pregnancy outcome in pregnancies complicated by fetal growth restriction and severe preeclampsia. QJM. 2024;117(Supplement_1).

Trivedi Z, Gokhale A, Agarwal S, Bhatt V. Fetal and maternal outcome of severe pre-eclampsia remote from term: expectant versus interventional management. Int J Reprod Contracept Obstet Gynecol. 2023;12(4):1116-22.